Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Award for work on hypertension

28.11.2005


During the congress of the Sociedad Española de Cardiología (Spanish Cardiology Association), held recently in Barcelona, specialists from Navarre received the prize for the best paper presented, from amongst the hundreds presented. It involved research on hypertension undertaken jointly by scientists from the Navarre Health Service and two centres at the University of Navarra: the Centre for Applied Medical Research (CIMA) and the University Hospital.



The paper was entitled, "La cardiotrofina-1 plasmática es un marcador del desarrollo y la regresión de la hipertrofia ventricular izquierda en los pacientes hipertensos" (Plasma cardiotrophin-1 is a marker for the development and regression of left ventrical hypertrophy in patients with high blood pressure).

This line of research with cardiotrophin-1 was initiated in 2003 and already this year it has been published twice in the international Journal of Hypertension magazine and in presentations in two European congresses, Cardiology and Hypertension.


Cardiotrophin-1, from the heart to the blood

Cardiotrophin-1 is a protein present in the blood, when produced in excess in the heart when it is subject to overload. An example of this added force is the situation of increased blood pressure typical in patients with high blood pressure.

The study showed two things: The abnormal increase of the concentration of cardiotrophin-1 in the blood is associated with the exaggerated growth (hypertrophia) of the in patients with high blood pressure; and that in treated patients its drop coincided with reduction in a cardiac hypertrophy. Moreover, the findings suggest the measurement of this cardiotrophin-1 would be a simpler, more reliable and cheaper method than the currently available methods for detecting the presence of heart hypertrophy of the heart in patients with high blood pressure.

The researchers suggest 3 reasons for investigating if the heart of a high blood pressure patient is hypertrophied or not: because not all pharmaceutical drugs employed to treat high blood pressure reduce cardiac hypertrophy, because the presence of hypertrophy is associated with a worse global cardiovascular prognosis of the patient and because it is the gateway to the two main complications of the heart that the high blood pressure patient is exposed to: cardiac insufficiency and auricular fibrillation.

Finally, the importance of the health problem is underlined by the fact that, today, two thirds of patients with high blood pressure suffer from this cardiac pathology (in Spain almost 5.5 million out of the 8 million patients with high blood pressure).

Garazi Andonegi | alfa
Further information:
http://www.basqueresearch.com

More articles from Health and Medicine:

nachricht Minimising risks of transplants
22.02.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

nachricht FAU researchers demonstrate that an oxygen sensor in the body reduces inflammation
22.02.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Developing reliable quantum computers

International research team makes important step on the path to solving certification problems

Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Stiffness matters

22.02.2018 | Life Sciences

Magnetic field traces gas and dust swirling around supermassive black hole

22.02.2018 | Physics and Astronomy

First evidence of surprising ocean warming around Galápagos corals

22.02.2018 | Earth Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>